Correlation between EEG abnormalities and symptoms of autism spectrum disorder (ASD).
Children with ASD often suffer from epilepsy and paroxysmal EEG abnormality. Purposes of this study are the confirmation of incidence of epileptic seizures and EEG abnormalities in children with autism using a high performance digital EEG, to examine the nature of EEG abnormalities such as locus or modality, and to determine if the development of children with ASD, who have experienced developmental delay, improves when their epilepsy has been treated and maintained under control. A total of 1014 autistic children that have been treated and followed-up for more than 3 years at Yasuhara Children's Clinic in Osaka, Japan, were included in this study. Each participant's EEG had been recorded approximately every 6 months under sleep conditions. Epilepsy was diagnosed in 37% (375/1014) of the study participants. Almost all patients diagnosed with epilepsy presented with symptomatic epilepsy. The data showed that the participants with lower IQ had a higher incidence of epileptic seizures. Epileptic EEG discharges occurred in 85.8% (870/1014) of the patients. There was also a very high incidence of spike discharges in participants whose intellectual quotient was very low or low. Epileptic seizure waves most frequently developed from the frontal lobe (65.6%), including the front pole (Fp1 and Fp2), frontal part (F3, F4, F7 and F8) and central part (C3, Cz and C4). The occurrence rate of spike discharges in other locations, including temporal lobe (T3, T4, T5, T6), parietal lobe (P3, Pz, P4), occipital lobe (O1, O2) and multifocal spikes was less than 10%. These results support the notion that there is a relationship between ASD and dysfunction of the mirror neuron system. The management of seizure waves in children diagnosed with ASD may result in improves function and reduction of autistic symptoms.
Yasuhara
Akihiro
A
Yasuhara Children's Clinic and YCC Education Center, Japan. akihiro-yasuhara@car.ocn.ne.jp
D000293:Adolescent; D017668:Age of Onset; D000375:Aging / Q000502:physiology / Q000523:psychology; D000927:Anticonvulsants / Q000627:therapeutic use; D020817:Asperger Syndrome / Q000503:physiopathology / Q000523:psychology; D001321:Autistic Disorder / Q000503:physiopathology* / Q000523:psychology*; D001931:Brain Mapping; D002648:Child; D002657:Child Development / Q000502:physiology; D002675:Child, Preschool; D002658:Developmental Disabilities / Q000503:physiopathology / Q000523:psychology; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004569:Electroencephalography; D004827:Epilepsy / Q000150:complications / Q000503:physiopathology; D005260:Female; D006801:Humans; D007361:Intelligence Tests; D007564:Japan; D008297:Male; D011597:Psychomotor Performance / Q000502:physiology; D012640:Seizures / Q000453:epidemiology; D012890:Sleep / Q000502:physiology; D012919:Social Behavior; D014635:Valproic Acid / Q000627:therapeutic use
D000927:Anticonvulsants; D014635:Valproic Acid